CIK 0000771856 · Non-accelerated filer<br>Smaller reporting company
CHAMPIONS ONCOLOGY, INC.
Sign in to watch- Ticker
- CSBR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521401755
- Phone
- 410-369-0365
- Business address
- 855 N. WOLFE STREET, SUITE 619, BALTIMORE, MD, 21205
- Former names
- CHAMPIONS BIOTECHNOLOGY, INC., CHAMPIONS SPORTS INC
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy President bought 30,000 shares at an average $1.66 ($49,900)
- 4 Open-market buy President bought 10,000 shares at $1.70 ($17,000)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $1.70 ($3,393)
- 4 Open-market buy President bought 10,305 shares at $1.66 ($17,106)
- 4 Open-market buy Chief Executive Officer bought 7,300 shares at an average $1.67 ($12,205)
- 8-K Event Shareholder vote results
- 4 Open-market buy President bought 29,695 shares at an average $1.67 ($49,494)
- 4 Open-market buy President bought 9,537 shares at $1.66 ($15,831)
- 4 Open-market buy Chief Executive Officer bought 8,202 shares at an average $1.63 ($13,369)
- 4 Open-market buy Chief Executive Officer bought 33 shares at $1.65 ($54)
Page 14 of 33 · 659 filings